The latest big deal proposed in the pharmaceuticals industry isn’t likely to happen.
Takeda Pharmaceutical recently approached Dublin-based Shire PLC. It emerged Thursday that the Japanese drug giant has made three separate offers to acquire Shire, the last of which amounted to about $60 billion in stock and cash, but Shire said it has rejected all three offers.
...